Latest Insider Transactions at Aclaris Therapeutics, Inc. (ACRS)
This section provides a real-time view of insider transactions for Aclaris Therapeutics, Inc. (ACRS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aclaris Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aclaris Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.33%
|
$345,000
$23.15 P/Share
|
|
Jun 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,189
+15.8%
|
-
|
|
Jun 01
2021
|
David N. Gordon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,000
-3.63%
|
$322,000
$23.14 P/Share
|
|
Jun 01
2021
|
David N. Gordon Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
87,500
+30.87%
|
-
|
|
May 07
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,416
-1.83%
|
$124,568
$23.61 P/Share
|
|
May 07
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,416
+3.51%
|
$54,160
$10.66 P/Share
|
|
May 06
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.81%
|
$345,000
$23.59 P/Share
|
|
May 06
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.64%
|
$150,000
$10.66 P/Share
|
|
May 05
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.74%
|
$360,000
$24.17 P/Share
|
|
May 05
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.64%
|
$150,000
$10.66 P/Share
|
|
May 04
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.77%
|
$360,000
$24.04 P/Share
|
|
May 04
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.64%
|
$150,000
$10.66 P/Share
|
|
May 03
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-4.83%
|
$360,000
$24.68 P/Share
|
|
May 03
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.64%
|
$150,000
$10.66 P/Share
|
|
Apr 26
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,339
-7.64%
|
$710,814
$26.12 P/Share
|
|
Apr 23
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-7.21%
|
$780,000
$26.99 P/Share
|
|
Apr 22
2021
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
30,000
-2.45%
|
$780,000
$26.84 P/Share
|
|
Apr 22
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-12.55%
|
$780,000
$26.84 P/Share
|
|
Mar 11
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
7,500
-6.14%
|
-
|
|
Mar 02
2021
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,982
-0.65%
|
$183,586
$23.25 P/Share
|
|
Mar 02
2021
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,253
+1.46%
|
-
|
|
Mar 02
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,844
-1.18%
|
$65,412
$23.25 P/Share
|
|
Mar 02
2021
|
Frank Ruffo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,297
+3.32%
|
-
|
|
Mar 02
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,906
-1.31%
|
$43,838
$23.25 P/Share
|
|
Mar 02
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,637
+4.36%
|
-
|
|
Mar 02
2021
|
David N. Gordon Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,280
-2.06%
|
$52,440
$23.25 P/Share
|
|
Mar 02
2021
|
David N. Gordon Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,297
+6.97%
|
-
|
|
Mar 01
2021
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
39,792
-3.18%
|
$955,008
$24.06 P/Share
|
|
Mar 01
2021
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
96,150
+7.13%
|
-
|
|
Mar 01
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,333
-3.04%
|
$175,992
$24.06 P/Share
|
|
Mar 01
2021
|
Frank Ruffo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,750
+9.66%
|
-
|
|
Mar 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,934
-3.43%
|
$118,416
$24.06 P/Share
|
|
Mar 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,175
+10.67%
|
-
|
|
Mar 01
2021
|
David N. Gordon Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,660
-5.23%
|
$135,840
$24.06 P/Share
|
|
Mar 01
2021
|
David N. Gordon Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,600
+16.0%
|
-
|
|
Feb 02
2021
|
Anand Mehra |
BUY
Exercise of conversion of derivative security
|
Direct |
14,632
+21.27%
|
$263,376
$18.34 P/Share
|
|
Feb 01
2021
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,316
-0.29%
|
$69,636
$21.35 P/Share
|
|
Feb 01
2021
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,800
+0.92%
|
-
|
|
Feb 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,318
-1.03%
|
$27,678
$21.35 P/Share
|
|
Feb 01
2021
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,875
+2.94%
|
-
|
|
Feb 01
2021
|
Frank Ruffo Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,308
-0.6%
|
$27,468
$21.35 P/Share
|
|
Feb 01
2021
|
Frank Ruffo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,875
+1.76%
|
-
|
|
Dec 15
2020
|
Kamil Ali Jackson Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
498
-0.4%
|
$1,992
$4.59 P/Share
|
|
Dec 15
2020
|
Kamil Ali Jackson Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,734
+1.37%
|
-
|
|
Dec 15
2020
|
Frank Ruffo Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
370
-0.17%
|
$1,480
$4.59 P/Share
|
|
Dec 15
2020
|
Frank Ruffo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+0.61%
|
-
|
|
Dec 15
2020
|
Neal Walker INTERIM CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-0.08%
|
$3,484
$4.59 P/Share
|
|
Dec 15
2020
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,034
+0.26%
|
-
|
|
Jun 27
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
699,475
-12.94%
|
$1,398,950
$2.69 P/Share
|
|
Jun 26
2019
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,704
-0.03%
|
$6,816
$4.5 P/Share
|